Aberrant migration of smooth muscle cells (SMCs) is a key feature of restenosis. Since extracellular matrix proteins and their receptors of the integrin family play a critical role in this process, it is instrumental to understand their contribution to cell migration and invasive motility of SMC on the molecular level. Therefore, we investigated the role of a v -containing integrins expressed by primary human coronary artery smooth muscle cells (hCASMCs) in vitronectin (VN)-initiated signaling events and cell migration. In hCASMC plated on VN, a v -containing integrins were localized at focal adhesion sites. Haptotactic stimulation through VN led to a dose-dependent increase in cell migration and concomitantly to enhanced tyrosine phosphorylation of focal adhesion kinase. Both events were completely blocked by a specific inhibitor of integrin a v . Additionally, the integrin a v inhibitor abolished PDGF-BB-stimulated chemotactic migration. Confocal microscopy confirmed the increased tyrosine phosphorylation at VN-initiated focal contact sites in hCASMC, that was abolished upon a v inhibition. In vitro invasion of hCASMC was severely compromised in the presence of the integrin a v inhibitor paralleled by decreased levels of secreted matrix metalloprotease 2 (MMP-2). Together, integrin a v inhibition abrogates tyrosine phosphorylation at focal adhesion sites and diminishes MMP-2 secretion leading to reduced migration and invasion of hCASMCs. Ó 2005 Elsevier Inc. All rights reserved.Keywords: Cell adhesion; Extracellular matrix proteins; Tyrosine phosphorylation; Vitronectin Percutaneous transluminal coronary angioplasty (PTCA) in combination with coronary stent implantation is an accepted treatment of angina pectoris or after myocardial infarction. However, despite recent progress in stent design and despite the introduction of drug-eluting stents, restenosis, the re-narrowing of the dilated blood vessel, is still a major drawback of PTCA. Restenosis occurs in approximately 10-20% of the patients, depending on their individual cardiovascular risk profile [1,2].The pathophysiology of restenosis after PTCA or stent implantation is well described (for review [3]). Immediately after the intervention, an early inflammatory response characterized by the recruitment and adhesion of leucocytes, macrophages, and activated platelets to the site of the vessel injury can be observed. In addition to various growth factors and cytokines released locally by resident and recruited cells, plasma proteins such as vitronectin, osteopontin, and fibronectin are deposited at the site of the lesion [4][5][6][7]. A combination of these chemotactic and haptotactic stimuli drives the proliferation and migration of vascular cells, mainly smooth muscle cells (SMCs), leading to their accumulation in the newly formed neointima. The migration of SMC from the media to the blood vessel lumen as well as their phenotypic change to a matrix protein secreting cell type contribute to the re-narrowing of the vessel. The result of this 0006-291X...